Dr Joseph Bridger Cox, MD | |
14100 Parkway Commons Dr Ste 100, Oklahoma City, OK 73134-6036 | |
(405) 748-3300 | |
(405) 749-1671 |
Full Name | Dr Joseph Bridger Cox |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 17 Years |
Location | 14100 Parkway Commons Dr Ste 100, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013117688 | NPI | - | NPPES |
008602601 | Medicaid | FL |
Facility Name | Location | Facility Type |
---|---|---|
Oklahoma Spine Hospital | Oklahoma city, OK | Hospital |
Mercy Hospital Ardmore, Inc | Ardmore, OK | Hospital |
Duncan Regional Hospital, Inc | Duncan, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Neuroscience Specialists Pc | 3375456718 | 17 |
News Archive
Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing. Researchers are therefore looking for proxy markers that after initiation of cancer therapy can reliably predict as quickly as possible whether the treatment has a benefit.
Study findings strengthen the suggestion that visit-to-visit variability in blood pressure is at least partly accounted for by patients' adherence or otherwise to their antihypertensive medication.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
In a continued effort to keep screening for childhood obesity at the forefront, Anthem Blue Cross' State Sponsored Business launched an innovative on-line Body Mass Index (BMI) training course featuring a virtual BMI wheel and web-based interactive practice sessions to help provide hands-on experience.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
› Verified 5 days ago
Entity Name | Neuroscience Specialists Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548239494 PECOS PAC ID: 3375456718 Enrollment ID: O20031111000359 |
News Archive
Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing. Researchers are therefore looking for proxy markers that after initiation of cancer therapy can reliably predict as quickly as possible whether the treatment has a benefit.
Study findings strengthen the suggestion that visit-to-visit variability in blood pressure is at least partly accounted for by patients' adherence or otherwise to their antihypertensive medication.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
In a continued effort to keep screening for childhood obesity at the forefront, Anthem Blue Cross' State Sponsored Business launched an innovative on-line Body Mass Index (BMI) training course featuring a virtual BMI wheel and web-based interactive practice sessions to help provide hands-on experience.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joseph Bridger Cox, MD 14100 Parkway Commons Dr Ste 100, Oklahoma City, OK 73134-6036 Ph: (405) 748-3300 | Dr Joseph Bridger Cox, MD 14100 Parkway Commons Dr Ste 100, Oklahoma City, OK 73134-6036 Ph: (405) 748-3300 |
News Archive
Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing. Researchers are therefore looking for proxy markers that after initiation of cancer therapy can reliably predict as quickly as possible whether the treatment has a benefit.
Study findings strengthen the suggestion that visit-to-visit variability in blood pressure is at least partly accounted for by patients' adherence or otherwise to their antihypertensive medication.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
In a continued effort to keep screening for childhood obesity at the forefront, Anthem Blue Cross' State Sponsored Business launched an innovative on-line Body Mass Index (BMI) training course featuring a virtual BMI wheel and web-based interactive practice sessions to help provide hands-on experience.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
› Verified 5 days ago
Dr. Christopher Salvatore Graffeo, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1000 N Lincoln Blvd, Oklahoma City, OK 73104 Phone: 602-406-3489 | |
Stan Pelofsky, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 4120 W Memorial Rd, Suite 300, Oklahoma City, OK 73120 Phone: 405-748-3300 Fax: 405-749-1671 | |
Michael D Martin, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 N Lincoln Blvd, Ste 400, Oklahoma City, OK 73104 Phone: 405-271-4912 | |
Dr. Paul C Francel, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 13825 Quail Pointe Dr, Oklahoma City, OK 73134 Phone: 405-424-5634 Fax: 405-692-6626 | |
Lance M Villeneuve, MD, PHD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd Ste 400, Oklahoma City, OK 73104 Phone: 405-271-4912 | |
Jeremy Phelps, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 250, Oklahoma City, OK 73112 Phone: 405-552-0401 Fax: 405-848-3210 |